Problem

ClaimGlide addresses the administrative and financial burden of insurer-mandated prior authorization for specialty and other private medical practices. The process is labor-intensive, delays treatment, and can cause otherwise payable claims to be denied when authorization is missing or mishandled. The AMA reports that practices complete an average of 39 prior-authorization requests per physician each week, consuming about 13 hours of physician and staff time; nationally, prior authorization is estimated to cost physicians $26.7 billion annually. Denial rework adds further expense, averaging about $25 per claim for medical practices.

The central use case is helping a practice secure approval for a treatment or procedure without dedicating staff to repetitive form completion, payer follow-up, phone calls, and appeals. By increasing approval rates and speeding authorization, ClaimGlide aims to protect practice revenue while reducing delays and administrative stress for staff and patients.

Product / Service

ClaimGlide is a custom AI prior-authorization automation platform that integrates into a practice’s existing workflows and electronic medical record systems. It extracts provider, patient, and diagnosis information from the EMR, creates and submits payer-specific authorization requests, and uses language intended to improve the likelihood of approval. It then tracks authorization status and payer timelines, flags delays, and follows up so requests do not fall through the cracks.

The platform also covers the denial and documentation lifecycle: it generates and submits appeal letters, conducts payer phone calls for appeals, and stores authorization confirmation numbers and supporting documents in the practice-management system. The company says it is HIPAA-compliant and integrates with systems including eClinicalWorks, athenahealth, NextGen Healthcare, and ModMed. The intended benefit is faster approvals, fewer preventable denials, higher practice revenue, and less manual work without requiring practices to replace their existing systems.

Market

ClaimGlide competes in healthcare AI, prior-authorization automation, and the broader provider revenue-cycle and administrative-workflow software market. Its positioning is particularly focused on private medical and specialty practices, while larger or adjacent competitors include Cohere Health, whose provider platform automates clinical-data extraction and authorization submissions; Infinitus, which specializes in voice-AI payer follow-up calls; and Waystar, which offers end-to-end authorization automation for physician practices, hospitals, and health systems.

The company appears to be at an early commercial stage. Y Combinator lists ClaimGlide as founded in 2025, part of Winter 2026, active, and operating with a one-person team; public funding databases report a $500,000 deal involving Y Combinator. The reviewed sources do not disclose customer count, revenue, or confirmed production-scale traction, so ClaimGlide should be described as funded and active but with revenue status undisclosed rather than definitively pre-revenue.